As of September 2024, Hansa Biopharma AB (publ) has a market cap of $241.15M. This makes Hansa Biopharma AB (publ) the world's 16083th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $172.39M | 30.15% |
2023 | $132.45M | -46.77% |
2022 | $248.83M | -44.57% |
2021 | $448.93M | -63.06% |
2020 | $1.22B | 186.70% |
2019 | $423.90M | -69.71% |
2018 | $1.40B | 10.94% |
2017 | $1.26B | 114.16% |
2016 | $588.96M | 360.47% |
2015 | $127.90M | -6.86% |
2014 | $137.32M | 223.45% |
2013 | $42.45M | 127.85% |
2012 | $18.63M | -13.66% |
2011 | $21.58M | 12.09% |
2010 | $19.25M | -6.73% |
2009 | $20.64M | 27.69% |
2008 | $16.17M | -40.14% |
2007 | $27.01M | - |